Capricor Therapeutics (CAPR) Receivables - Other (2012 - 2025)
Capricor Therapeutics (CAPR) reported Receivables - Other of $59,167 for Q4 2025, down 99.4% from $10.37 million a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Capricor Therapeutics (CAPR) Receivables - Other (2012 - 2025) Analysis & Trends
Dating back to Q4 2012, Capricor Therapeutics' Receivables - Other record includes 47 quarters.
- Receivables - Other has a five-year compound annual growth rate of 1.1% (FY2020 to FY2025).
- By year, Receivables - Other came in at $10.37 million in FY2024 (unchanged), $10.37 million in FY2023, $547,580 in FY2022 (+39.8%) and $391,750 in FY2021 (+599.6%).
- Five-year quarterly Receivables - Other spans a low of $59,167 in Q3 2025 and a high of $10.37 million in Q4 2023.
- Year over year, Receivables - Other has now declined in each of the last four quarters, with an average decline of 55.4% over the last eight quarters.
- The high point for year-over-year Receivables - Other in five years was Q4 2021 (growth of 599.6%); the low point was Q4 2025 (a decline of 99.4%).
- Per Business Quant data, the three quarters before Q4 2025 came in at $59,167 (Q3 2025), $59,509 (Q2 2025) and $59,834 (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Capricor Therapeutics | 506.13 Mn | 506.13 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 59,167.00 |
| Sep 30, 2025 | 59,167.00 |
| Jun 30, 2025 | 59,509.00 |
| Mar 31, 2025 | 59,834.00 |
| Dec 31, 2024 | 10.37 Mn |
| Sep 30, 2024 | 409,682.00 |
| Jun 30, 2024 | 369,975.00 |
| Mar 31, 2024 | 369,000.00 |
| Dec 31, 2023 | 10.37 Mn |
| Sep 30, 2023 | 547,580.00 |
| Jun 30, 2023 | 547,580.00 |
| Mar 31, 2023 | 547,580.00 |
| Dec 31, 2022 | 547,580.00 |
| Sep 30, 2022 | 547,580.00 |
| Jun 30, 2022 | 547,580.00 |
| Mar 31, 2022 | 356,997.00 |
| Dec 31, 2021 | 391,750.00 |
| Sep 30, 2021 | 180,178.00 |
| Jun 30, 2021 | 206,000.00 |
| Mar 31, 2021 | 600,000.00 |
API Access
Capricor Therapeutics Receivables - Other API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-other&ticker=CAPR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-other", "ticker": "CAPR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-other&ticker=CAPR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();